About Us
Our team of researchers is a dedicated and diverse team of physicians and allied health professionals with expertise in the treatment of HIV, hepatitis B, hepatitis C, Nonalcoholic Steatohepatitis (NASH) and HIV prevention (PrEP). Our research institute has conducted nearly 200 clinical trials, studying the newest therapies available from the leading international biopharmaceutical companies.
Our current team includes 4 Sub-Investigators, 1 Clinical Research Director, 5 Clinical Research Coordinators, 4 Clinical Research Associates, 4 Research Assistants, and 1 Regulatory Specialist working under the supervision of the Principal Investigator. Our team works on pharmaceutical-sponsored clinical trials in addition to publishing results from Investigator-Initiated Studies.